| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.7M | -7.7% |
| Cost of Revenue | $25.5M | -18.6% |
| Gross Profit | $2.2M | +267.9% |
| R&D Expense | $197K | -57.2% |
| SG&A Expense | $22.6M | +21.2% |
| Operating Income | -$20.4M | -297.7% |
| Income Tax | -$135K | — |
| Net Income | -$25.3M | -761.1% |
| EPS (Basic) | -$1.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.0M | +10.7% |
| Inventory | $8.0M | +15.9% |
| Current Assets | $11.8M | +9515.4% |
| Total Assets | $60.0M | +172.2% |
| Current Liabilities | $25.4M | +239.3% |
| Total Liabilities | $60.7M | -30.3% |
| Stockholders' Equity | -$696K | +90.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.1M | -545.2% |
| Capital Expenditures | $1.7M | -63.0% |
| Investing Cash Flow | -$1.9M | -101.2% |
| Financing Cash Flow | $10.0M | +106.4% |
| Free Cash Flow | -$16.7M | -146.0% |
| +51.2% |
| EPS (Diluted) | -$1.25 | +51.2% |